Poornima Indu G, Miller Todd D, Christian Timothy F, Hodge David O, Bailey Kent R, Gibbons Raymond J
Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
J Am Coll Cardiol. 2004 Jan 21;43(2):194-9. doi: 10.1016/j.jacc.2003.09.029.
The purpose of this study was to determine whether a previously validated clinical score (CS) could identify patients with a low-risk Duke treadmill score who had a higher risk of adverse events and, therefore, in whom myocardial perfusion imaging would be valuable for risk stratification.
Current American College of Cardiology/American Heart Association guidelines recommend using a standard exercise test without imaging as the initial test in patients who have an interpretable electrocardiogram and are able to exercise.
We studied 1,461 symptomatic patients with low-risk Duke treadmill scores (> or =5) who underwent myocardial perfusion imaging. The CS was derived by assigning one point to each of the following variables: typical angina, history of myocardial infarction, diabetes, insulin use, male gender, and each decade of age over 40 years. A CS cutoff > or =5 or <5 was used to categorize patients as high risk (n = 303 [21%]) or low risk (n = 1,158 [79%]). Perfusion scans were categorized as low, intermediate, or high risk on the basis of the global stress score (GSS).
High-risk scans were more common in patients with a high-risk CS (26.4% vs. 9.5%, p < 0.0001). The CS and GSS were significant independent predictors of cardiac death. However, in patients with a low CS, seven-year cardiac survival was excellent, regardless of the GSS (99% for normal scans, 99% for mildly abnormal scans, and 99% for severely abnormal scans). In contrast, patients with a high CS had a lower seven-year survival rate (92%), which varied with GSS (94% for normal scans, 94% for mildly abnormal scans, and 84% for severely abnormal scans; p < 0.001).
In symptomatic patients with low-risk Duke treadmill scores and low clinical risk, myocardial perfusion imaging is of limited prognostic value. In patients with low-risk Duke treadmill scores and high clinical risk, annual cardiac mortality (>1%) is not low, and myocardial perfusion imaging has independent prognostic value.
本研究旨在确定一种先前经验证的临床评分(CS)能否识别杜克运动平板评分低但不良事件风险较高的患者,从而确定心肌灌注成像对其进行危险分层是否有价值。
美国心脏病学会/美国心脏协会现行指南建议,对于心电图可解读且能够运动的患者,将无成像的标准运动试验作为初始检查。
我们研究了1461例有症状且杜克运动平板评分低(≥5)并接受心肌灌注成像的患者。CS通过对以下每个变量赋予1分得出:典型心绞痛、心肌梗死病史、糖尿病、使用胰岛素、男性以及40岁以上每增加十岁。CS临界值≥5或<5用于将患者分为高危(n = 303 [21%])或低危(n = 1158 [79%])。根据整体应激评分(GSS)将灌注扫描分为低危、中危或高危。
高危扫描在高危CS患者中更常见(26.4%对9.5%,p<0.0001)。CS和GSS是心脏死亡的显著独立预测因素。然而,在CS低的患者中,无论GSS如何,七年心脏生存率都很高(正常扫描为99%,轻度异常扫描为99%,重度异常扫描为99%)。相比之下,CS高的患者七年生存率较低(92%),且随GSS变化(正常扫描为94%,轻度异常扫描为94%,重度异常扫描为84%;p<0.001)。
在杜克运动平板评分低且临床风险低的有症状患者中,心肌灌注成像的预后价值有限。在杜克运动平板评分低且临床风险高的患者中,年度心脏死亡率(>1%)不低,且心肌灌注成像具有独立的预后价值。